| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 67 | 2022 | 720 | 10.420 |
Why?
|
| Genetic Vectors | 54 | 2022 | 3403 | 5.950 |
Why?
|
| Capsid | 14 | 2022 | 435 | 3.110 |
Why?
|
| Transduction, Genetic | 27 | 2022 | 899 | 2.940 |
Why?
|
| Gene Transfer Techniques | 21 | 2022 | 1207 | 2.190 |
Why?
|
| Capsid Proteins | 13 | 2022 | 468 | 1.920 |
Why?
|
| Virus Assembly | 2 | 2019 | 141 | 1.190 |
Why?
|
| Viral Vaccines | 2 | 2022 | 596 | 1.020 |
Why?
|
| Retinal Cone Photoreceptor Cells | 3 | 2018 | 183 | 0.970 |
Why?
|
| Retinal Degeneration | 5 | 2016 | 414 | 0.950 |
Why?
|
| Retinal Diseases | 3 | 2018 | 710 | 0.950 |
Why?
|
| Blindness | 3 | 2016 | 587 | 0.730 |
Why?
|
| Transgenes | 12 | 2021 | 1016 | 0.690 |
Why?
|
| Macaca | 6 | 2022 | 413 | 0.690 |
Why?
|
| Retina | 12 | 2018 | 2662 | 0.680 |
Why?
|
| Genome, Viral | 5 | 2019 | 674 | 0.670 |
Why?
|
| Parvovirinae | 1 | 2019 | 10 | 0.660 |
Why?
|
| Cochlea | 6 | 2022 | 848 | 0.650 |
Why?
|
| Retinoschisis | 1 | 2018 | 30 | 0.600 |
Why?
|
| Antibodies, Neutralizing | 5 | 2022 | 2009 | 0.590 |
Why?
|
| Green Fluorescent Proteins | 15 | 2022 | 2065 | 0.580 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 3214 | 0.550 |
Why?
|
| Photoreceptor Cells | 4 | 2022 | 234 | 0.550 |
Why?
|
| Leber Congenital Amaurosis | 2 | 2016 | 36 | 0.550 |
Why?
|
| Conserved Sequence | 1 | 2019 | 1162 | 0.530 |
Why?
|
| Color Vision Defects | 1 | 2016 | 28 | 0.510 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2018 | 204 | 0.510 |
Why?
|
| Gene Targeting | 1 | 2019 | 841 | 0.500 |
Why?
|
| Parvoviridae Infections | 4 | 2009 | 39 | 0.480 |
Why?
|
| Viral Tropism | 2 | 2016 | 102 | 0.480 |
Why?
|
| Animals | 74 | 2023 | 169285 | 0.460 |
Why?
|
| Virus Internalization | 1 | 2018 | 503 | 0.450 |
Why?
|
| Eye | 1 | 2017 | 712 | 0.430 |
Why?
|
| Viral Load | 2 | 2021 | 3396 | 0.420 |
Why?
|
| Mice | 46 | 2023 | 82049 | 0.410 |
Why?
|
| Plasmids | 2 | 2017 | 2269 | 0.410 |
Why?
|
| Macaca mulatta | 6 | 2022 | 2363 | 0.400 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1035 | 0.400 |
Why?
|
| Serotyping | 8 | 2018 | 331 | 0.390 |
Why?
|
| Virus Release | 1 | 2010 | 35 | 0.360 |
Why?
|
| HEK293 Cells | 8 | 2019 | 4280 | 0.340 |
Why?
|
| Usher Syndromes | 2 | 2022 | 56 | 0.320 |
Why?
|
| Culture Media | 1 | 2010 | 898 | 0.300 |
Why?
|
| Virion | 3 | 2019 | 429 | 0.300 |
Why?
|
| Deafness | 1 | 2012 | 460 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 20 | 2021 | 22380 | 0.280 |
Why?
|
| Liver | 11 | 2022 | 7578 | 0.270 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2019 | 124 | 0.270 |
Why?
|
| Amino Acid Motifs | 2 | 2019 | 930 | 0.270 |
Why?
|
| Macaca fascicularis | 5 | 2021 | 912 | 0.260 |
Why?
|
| Phylogeny | 9 | 2019 | 2843 | 0.260 |
Why?
|
| Protein Stability | 2 | 2018 | 579 | 0.250 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2893 | 0.240 |
Why?
|
| Retinal Ganglion Cells | 2 | 2022 | 811 | 0.230 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2022 | 783 | 0.220 |
Why?
|
| Heparin | 2 | 2010 | 1636 | 0.210 |
Why?
|
| Antibody Formation | 1 | 2007 | 1393 | 0.210 |
Why?
|
| Hearing Loss | 2 | 2022 | 785 | 0.200 |
Why?
|
| Hair Cells, Auditory, Inner | 3 | 2022 | 197 | 0.200 |
Why?
|
| Baculoviridae | 2 | 2020 | 115 | 0.200 |
Why?
|
| Immune Tolerance | 2 | 2009 | 2323 | 0.200 |
Why?
|
| Eye Proteins | 2 | 2018 | 628 | 0.190 |
Why?
|
| T-Lymphocytes | 7 | 2021 | 10266 | 0.190 |
Why?
|
| Humans | 62 | 2022 | 768171 | 0.190 |
Why?
|
| Immunity, Cellular | 1 | 2007 | 1561 | 0.190 |
Why?
|
| Dysautonomia, Familial | 1 | 2022 | 94 | 0.190 |
Why?
|
| Disease Models, Animal | 12 | 2022 | 18349 | 0.180 |
Why?
|
| Mucolipidoses | 1 | 2021 | 82 | 0.180 |
Why?
|
| Ear, Inner | 2 | 2022 | 426 | 0.180 |
Why?
|
| Technology Transfer | 1 | 2020 | 41 | 0.180 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2021 | 130 | 0.170 |
Why?
|
| Apoptosis | 1 | 2016 | 9527 | 0.170 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2018 | 23 | 0.160 |
Why?
|
| Biotechnology | 1 | 2021 | 283 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 6231 | 0.160 |
Why?
|
| Adenoviridae Infections | 2 | 2009 | 96 | 0.160 |
Why?
|
| Cell Line | 7 | 2019 | 15602 | 0.150 |
Why?
|
| Optic Nerve Diseases | 1 | 2022 | 342 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 3056 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 548 | 0.150 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 406 | 0.150 |
Why?
|
| Cell Nucleus | 2 | 2019 | 2885 | 0.150 |
Why?
|
| Pan troglodytes | 3 | 2008 | 224 | 0.150 |
Why?
|
| Clinical Trials as Topic | 4 | 2020 | 8052 | 0.140 |
Why?
|
| Protective Agents | 1 | 2018 | 151 | 0.140 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 472 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 450 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8759 | 0.140 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1662 | 0.140 |
Why?
|
| Trabecular Meshwork | 1 | 2017 | 101 | 0.140 |
Why?
|
| Adenoviridae | 3 | 2010 | 1093 | 0.140 |
Why?
|
| Labyrinth Diseases | 1 | 2018 | 151 | 0.130 |
Why?
|
| Receptors, Cell Surface | 3 | 2018 | 2819 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2018 | 5402 | 0.130 |
Why?
|
| Research Personnel | 1 | 2021 | 589 | 0.130 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1377 | 0.130 |
Why?
|
| Color Vision | 1 | 2016 | 23 | 0.130 |
Why?
|
| Integrases | 1 | 2018 | 520 | 0.130 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2018 | 283 | 0.130 |
Why?
|
| Thermodynamics | 1 | 2017 | 591 | 0.120 |
Why?
|
| Cryoelectron Microscopy | 1 | 2019 | 648 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2011 | 1524 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2007 | 3080 | 0.120 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2018 | 309 | 0.120 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2017 | 694 | 0.120 |
Why?
|
| Retinal Bipolar Cells | 1 | 2014 | 46 | 0.120 |
Why?
|
| Biological Transport | 1 | 2019 | 2085 | 0.120 |
Why?
|
| Receptors, Virus | 2 | 2011 | 651 | 0.110 |
Why?
|
| Vestibular Diseases | 1 | 2017 | 232 | 0.110 |
Why?
|
| Virus Cultivation | 2 | 2010 | 88 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2019 | 936 | 0.110 |
Why?
|
| Workflow | 1 | 2019 | 860 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2023 | 1334 | 0.110 |
Why?
|
| Vaccines | 1 | 2022 | 843 | 0.110 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2016 | 462 | 0.110 |
Why?
|
| Directed Molecular Evolution | 1 | 2014 | 165 | 0.110 |
Why?
|
| Protein Transport | 1 | 2019 | 1951 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2018 | 966 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1094 | 0.100 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2015 | 271 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2012 | 30 | 0.100 |
Why?
|
| Stifle | 1 | 2012 | 28 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 873 | 0.100 |
Why?
|
| Amino Acids | 1 | 2019 | 1716 | 0.100 |
Why?
|
| AIDS Vaccines | 2 | 2009 | 900 | 0.100 |
Why?
|
| Exosomes | 1 | 2017 | 423 | 0.100 |
Why?
|
| Horse Diseases | 1 | 2012 | 55 | 0.100 |
Why?
|
| Neuromuscular Diseases | 1 | 2015 | 260 | 0.100 |
Why?
|
| Primates | 2 | 2013 | 520 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2018 | 14488 | 0.100 |
Why?
|
| Viral Matrix Proteins | 2 | 2003 | 193 | 0.100 |
Why?
|
| Ear | 1 | 2012 | 172 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2892 | 0.100 |
Why?
|
| Receptors, LDL | 2 | 2011 | 493 | 0.100 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 3713 | 0.090 |
Why?
|
| Intraocular Pressure | 1 | 2017 | 1304 | 0.090 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 256 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1408 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 1896 | 0.090 |
Why?
|
| Genome | 1 | 2019 | 1754 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2019 | 13422 | 0.090 |
Why?
|
| Ebolavirus | 2 | 2003 | 250 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2018 | 2100 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 324 | 0.090 |
Why?
|
| Auditory Pathways | 1 | 2012 | 238 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 17623 | 0.090 |
Why?
|
| Mutation | 5 | 2017 | 30237 | 0.090 |
Why?
|
| Polyethyleneimine | 1 | 2010 | 68 | 0.090 |
Why?
|
| Tropism | 1 | 2009 | 44 | 0.090 |
Why?
|
| Galactose | 1 | 2011 | 300 | 0.080 |
Why?
|
| Cornea | 1 | 2017 | 1316 | 0.080 |
Why?
|
| Selection, Genetic | 1 | 2014 | 877 | 0.080 |
Why?
|
| Trans-Splicing | 1 | 2009 | 8 | 0.080 |
Why?
|
| Hominidae | 1 | 2009 | 68 | 0.080 |
Why?
|
| Substantia Nigra | 1 | 2011 | 346 | 0.080 |
Why?
|
| Kupffer Cells | 1 | 2009 | 143 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3437 | 0.080 |
Why?
|
| Protein Binding | 3 | 2018 | 9343 | 0.080 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2011 | 407 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2022 | 1327 | 0.080 |
Why?
|
| Genes, gag | 1 | 2008 | 59 | 0.080 |
Why?
|
| Phenotype | 4 | 2022 | 16726 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2017 | 19025 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2017 | 4939 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2014 | 1076 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2016 | 1346 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 1996 | 0.070 |
Why?
|
| CHO Cells | 2 | 2011 | 1379 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2013 | 880 | 0.070 |
Why?
|
| Mice, Inbred mdx | 2 | 2019 | 90 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3517 | 0.070 |
Why?
|
| Male | 20 | 2021 | 364731 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 2631 | 0.070 |
Why?
|
| Cricetinae | 2 | 2011 | 2423 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 5505 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3409 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14729 | 0.070 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 556 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2011 | 1801 | 0.060 |
Why?
|
| Forecasting | 1 | 2015 | 2945 | 0.060 |
Why?
|
| Muscles | 2 | 2007 | 1582 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 453 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2008 | 659 | 0.060 |
Why?
|
| Skin | 1 | 2019 | 4505 | 0.060 |
Why?
|
| Respiratory System | 1 | 2008 | 564 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
| Lung | 4 | 2011 | 10101 | 0.060 |
Why?
|
| Adenoviruses, Simian | 1 | 2004 | 16 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2011 | 1024 | 0.060 |
Why?
|
| Osteoarthritis | 1 | 2012 | 1072 | 0.060 |
Why?
|
| Exons | 3 | 2016 | 2394 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 838 | 0.060 |
Why?
|
| Trachea | 1 | 2010 | 1095 | 0.060 |
Why?
|
| Epithelium | 1 | 2008 | 1607 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 2007 | 960 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3604 | 0.060 |
Why?
|
| Caveolae | 1 | 2003 | 54 | 0.060 |
Why?
|
| Primate Diseases | 1 | 2003 | 15 | 0.050 |
Why?
|
| Dopamine | 1 | 2011 | 1592 | 0.050 |
Why?
|
| Transfection | 2 | 2010 | 5756 | 0.050 |
Why?
|
| Brain | 4 | 2021 | 27362 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 840 | 0.050 |
Why?
|
| Myocytes, Cardiac | 2 | 2023 | 1682 | 0.050 |
Why?
|
| Cell Cycle Proteins | 3 | 2022 | 3445 | 0.050 |
Why?
|
| Fetus | 1 | 2010 | 1883 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 892 | 0.050 |
Why?
|
| Feces | 1 | 2009 | 1511 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2003 | 361 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2006 | 1156 | 0.050 |
Why?
|
| Stapes | 1 | 2022 | 89 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2009 | 781 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8747 | 0.050 |
Why?
|
| Swine | 2 | 2022 | 5997 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2009 | 3161 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 2885 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11677 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 897 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2022 | 1309 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2006 | 3074 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20225 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2006 | 2603 | 0.040 |
Why?
|
| Hair Cells, Auditory | 1 | 2022 | 382 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2003 | 594 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3772 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1854 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 4428 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4413 | 0.040 |
Why?
|
| Kinetics | 1 | 2006 | 6330 | 0.040 |
Why?
|
| DNA | 1 | 2011 | 7213 | 0.040 |
Why?
|
| Recombination, Genetic | 3 | 2009 | 1525 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2016 | 1968 | 0.040 |
Why?
|
| Rats | 4 | 2021 | 23782 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3703 | 0.030 |
Why?
|
| Africa | 2 | 2009 | 725 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1406 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 2008 | 739 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2018 | 230 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 363 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1613 | 0.030 |
Why?
|
| Neurites | 1 | 2018 | 389 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2003 | 1895 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2011 | 7876 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 9561 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2009 | 169 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 1769 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 3115 | 0.030 |
Why?
|
| Pericytes | 1 | 2018 | 299 | 0.030 |
Why?
|
| Lysosomes | 1 | 2021 | 938 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 422 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 4648 | 0.030 |
Why?
|
| Intellectual Property | 1 | 2015 | 32 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2018 | 3589 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 213 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 401 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2006 | 2747 | 0.030 |
Why?
|
| Female | 7 | 2021 | 397187 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2010 | 3433 | 0.030 |
Why?
|
| Retinal Neovascularization | 1 | 2017 | 288 | 0.030 |
Why?
|
| Stem Cell Research | 1 | 2014 | 37 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 392 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.030 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 364 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 2395 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2023 | 2592 | 0.030 |
Why?
|
| Education, Continuing | 1 | 2014 | 115 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2017 | 65379 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2008 | 6610 | 0.030 |
Why?
|
| Genetic Research | 1 | 2014 | 173 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1623 | 0.030 |
Why?
|
| beta Catenin | 1 | 2018 | 1047 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2722 | 0.030 |
Why?
|
| DNA Primers | 2 | 2010 | 2828 | 0.030 |
Why?
|
| Horses | 1 | 2012 | 295 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1497 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 905 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11095 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 1683 | 0.020 |
Why?
|
| Fibrosis | 1 | 2018 | 2081 | 0.020 |
Why?
|
| Helper Viruses | 1 | 2010 | 39 | 0.020 |
Why?
|
| Neuraminidase | 1 | 2011 | 195 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2560 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2010 | 298 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2003 | 4415 | 0.020 |
Why?
|
| Triiodobenzoic Acids | 1 | 2010 | 123 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 794 | 0.020 |
Why?
|
| Government Regulation | 1 | 2015 | 525 | 0.020 |
Why?
|
| Axons | 1 | 2018 | 1677 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Herpesviridae | 1 | 2010 | 104 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 435 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 5797 | 0.020 |
Why?
|
| Hepatic Artery | 1 | 2011 | 232 | 0.020 |
Why?
|
| B-Lymphocytes | 3 | 2009 | 4793 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2017 | 5028 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2459 | 0.020 |
Why?
|
| Animals, Zoo | 1 | 2009 | 15 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2009 | 37 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 524 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 1951 | 0.020 |
Why?
|
| Adenovirus E3 Proteins | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 812 | 0.020 |
Why?
|
| Lac Operon | 1 | 2009 | 237 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 40220 | 0.020 |
Why?
|
| Glaucoma | 1 | 2018 | 1194 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5789 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2010 | 381 | 0.020 |
Why?
|
| Neurons | 1 | 2007 | 9514 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2009 | 655 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1100 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 1648 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2009 | 196 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2011 | 1989 | 0.020 |
Why?
|
| Macrophages | 1 | 2003 | 5802 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2015 | 12801 | 0.020 |
Why?
|
| Proteins | 1 | 2022 | 6009 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 4978 | 0.020 |
Why?
|
| Fixatives | 1 | 2007 | 90 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2009 | 404 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1379 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2009 | 528 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 6082 | 0.020 |
Why?
|
| Cell Movement | 1 | 2019 | 5213 | 0.020 |
Why?
|
| Rhodopsin | 1 | 2007 | 198 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 622 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 1890 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2018 | 2401 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2981 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1715 | 0.020 |
Why?
|
| Base Sequence | 2 | 2010 | 12422 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 3956 | 0.020 |
Why?
|
| Dogs | 1 | 2011 | 3845 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2008 | 619 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1599 | 0.020 |
Why?
|
| Mitochondria | 1 | 2018 | 3683 | 0.020 |
Why?
|
| Australia | 1 | 2009 | 1265 | 0.020 |
Why?
|
| Adenovirus Early Proteins | 1 | 2004 | 58 | 0.010 |
Why?
|
| Introns | 1 | 2007 | 965 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 1904 | 0.010 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 2003 | 23 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4585 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1184 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2122 | 0.010 |
Why?
|
| Caveolins | 1 | 2003 | 102 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1972 | 0.010 |
Why?
|
| Aging | 1 | 2022 | 8743 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4120 | 0.010 |
Why?
|
| Myocardium | 1 | 2015 | 4790 | 0.010 |
Why?
|
| Immunity | 1 | 2008 | 1003 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2003 | 255 | 0.010 |
Why?
|
| Europe | 1 | 2009 | 3436 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 412 | 0.010 |
Why?
|
| HIV Infections | 1 | 2008 | 17569 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 440 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2011 | 2714 | 0.010 |
Why?
|
| HIV-1 | 2 | 2009 | 6963 | 0.010 |
Why?
|
| Papio | 1 | 2003 | 671 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 518 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 818 | 0.010 |
Why?
|
| Geography | 1 | 2003 | 652 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2179 | 0.010 |
Why?
|
| Astrocytes | 1 | 2007 | 1350 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 2237 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 13091 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2018 | 23648 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1294 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 1505 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 2957 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 999 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 3623 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3590 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2004 | 2204 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8142 | 0.010 |
Why?
|
| Hippocampus | 1 | 2007 | 3783 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3740 | 0.010 |
Why?
|
| Artifacts | 1 | 2003 | 1926 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13668 | 0.010 |
Why?
|
| United States | 2 | 2014 | 73039 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 223646 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4786 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 3567 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 5812 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5151 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 30009 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39354 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11930 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 36535 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 171502 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 42669 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 60066 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36741 | 0.000 |
Why?
|
| Child | 1 | 2011 | 80917 | 0.000 |
Why?
|
| Adolescent | 1 | 2011 | 89169 | 0.000 |
Why?
|
| Middle Aged | 1 | 2011 | 223487 | 0.000 |
Why?
|